Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: Pooled analysis of two randomised controlled trials

Authors

Sholom Wacholder, National Cancer Institute
Bingshu Eric Chen, Queen's University - Kingston, Ontario
Allen Wilcox, National Institute of Environmental Health Sciences
George Macones, Washington University School of Medicine in St. LouisFollow
Paula Gonzalez, Fundación INCIENSA, Costa Rica
Brian Befano, Information Management Services, Siilver Spring, MD
Allan Hildesheim, National Cancer Institute
Ana Cecilia Rodriguez, Fundación INCIENSA, Costa Rica
Diane Solomon, National Cancer Institute
Rolando Herrero, Fundación INCIENSA, Costa Rica
Mark Schiffman, National Cancer Institute

Journal

BMJ

Publication Date

2010

Volume

340

Issue

7748

Inclusive Pages

696

Document Type

Open Access Publication

DOI

10.1136/bmj.c712

Rights and Permissions

Wacholder, S., Chen, B. E., Wilcox, A., Macones, G., Gonzalez, P., Befano, B., . . . Schiffman, M. (2010). Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: Pooled analysis of two randomised controlled trials. BMJ (Online), 340(7748), 696. DOI: 10.1136/bmj.c712

Recommended Citation

Wacholder, Sholom; Chen, Bingshu Eric; Wilcox, Allen; Macones, George; Gonzalez, Paula; Befano, Brian; Hildesheim, Allan; Rodriguez, Ana Cecilia; Solomon, Diane; Herrero, Rolando; and Schiffman, Mark, "Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: Pooled analysis of two randomised controlled trials." BMJ. 340, 7748. 696. (2010).
https://digitalcommons.wustl.edu/open_access_pubs/1485